Enovis (ENOV) Return on Capital Employed Growth (5y) (2016 - 2026)
Enovis (ENOV) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn |
| 10 | Enovis | 1.60 Bn | 1.56 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -3,237.00 |
| Dec 31, 2025 | -3,077.00 |
| Oct 3, 2025 | -3,407.00 |
| Jul 4, 2025 | -2,044.00 |
| Apr 4, 2025 | -2,199.00 |
| Dec 31, 2024 | -1,951.00 |
| Sep 27, 2024 | -403.00 |
| Jun 28, 2024 | -336.00 |
| Mar 29, 2024 | -327.00 |
| Dec 31, 2023 | -479.00 |
| Sep 29, 2023 | -353.00 |
| Dec 31, 2022 | -426.00 |
| Sep 30, 2022 | -650.00 |
| Jul 1, 2022 | -711.00 |
| Apr 1, 2022 | -677.00 |
| Dec 31, 2021 | -422.00 |
| Oct 1, 2021 | -612.00 |
| Jul 2, 2021 | -466.00 |
| Apr 2, 2021 | -504.00 |
| Dec 31, 2020 | -563.00 |